4//SEC Filing
Theagene Jean-Manasse 4
Accession 0001127602-24-011875
CIK 0001878313other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:52 PM ET
Size
5.2 KB
Accession
0001127602-24-011875
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2024-03-31+9,193→ 9,193 totalExercise: $2.20From: 2024-03-31Exp: 2034-03-31→ Common Stock (9,193 underlying)
Footnotes (1)
- [F1]The stock options, granted on March 31, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001969857
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:52 PM ET
- Size
- 5.2 KB